Evofem Biosciences (EVFM) Prepaid Assets (2014 - 2026)
Evofem Biosciences (EVFM) reported Prepaid Assets of $1.15 million for Q2 2026, down 17.1% from $1.38 million a year earlier and down 6.7% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Prepaid Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Evofem Biosciences posted Prepaid Assets of $1.1 million, down 24.8% from FY2024.
- Prepaid Assets has a five-year compound annual growth rate of -42.9% (FY2020 to FY2025).
- By year, Prepaid Assets came in at $1.46 million in FY2024 (+22.1%), $1.2 million in FY2023 (-46.1%), $2.22 million in FY2022 (-31.3%) and $3.23 million in FY2021 (-82.1%).
- Five-year quarterly Prepaid Assets spans a low of $622,000 in Q1 2024 and a high of $16.69 million in Q3 2021.
- Year over year, Prepaid Assets has now declined in each of the last four quarters, with growth averaging 11.5% over the last eight quarters.
- The high point for year-over-year Prepaid Assets in five years was Q1 2025 (growth of 117.4%); the low point was Q4 2021 (a decline of 82.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.23 million (Q1 2026), $1.1 million (Q4 2025) and $959,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.15 Mn |
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 959,000.00 |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 999,000.00 |
| Jun 30, 2024 | 845,000.00 |
| Mar 31, 2024 | 622,000.00 |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 2.51 Mn |
| Mar 31, 2023 | 2.10 Mn |
| Dec 31, 2022 | 2.22 Mn |
| Sep 30, 2022 | 4.81 Mn |
| Jun 30, 2022 | 7.19 Mn |
| Mar 31, 2022 | 4.63 Mn |
| Dec 31, 2021 | 3.23 Mn |
| Sep 30, 2021 | 16.69 Mn |
API Access
Evofem Biosciences Prepaid Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=prepaid-assets&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "prepaid-assets", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=prepaid-assets&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();